Adiposity and Endothelin Receptor Function
common.study.values.description
“Adiposity and Endothelin Receptor Function”
Elevated levels of ET-1 have been implicated in cardiovascular disease and some forms of hypertension. Due to the strong, positive correlation between obesity and hypertension, the present study will explore the contribution of adiposity in ETB receptor function and aim to elucidate if ETB receptor dysfunction is a major contributor to hypertension in obesity.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
 common.study.methods.has-drugs-yes
                                    common.study.methods.has-drugs-yes
                                 common.study.methods.is-healthy-no
                                        common.study.methods.is-healthy-no
                                Drug - Candesartan
7 days of Candesartan (16mg/day)
Drug - Placebo
7 days of Placebo
participant.views.study.view.additional
participant.views.study.view.scientific-title
Adiposity and Endothelin Receptor Function
common.study.values.clinical-trial-id
NCT03583866
participant.views.study.view.id
b4xxxb
 
    
    